Braat S - Search Results

1

Impaired GABAergic inhibition in the hippocampus of Fmr1 knockout mice.

Sabanov V, Braat S, D'Andrea L, Willemsen R, Zeidler S, Rooms L, Bagni C, Kooy RF, Balschun D. Sabanov V, et al. Among authors: braat s. Neuropharmacology. 2017 Apr;116:71-81. doi: 10.1016/j.neuropharm.2016.12.010. Epub 2016 Dec 21. Neuropharmacology. 2017. PMID: 28012946

2

Involvement and therapeutic potential of the GABAergic system in the fragile X syndrome.

Heulens I, D'Hulst C, Braat S, Rooms L, Kooy RF. Heulens I, et al. Among authors: braat s. ScientificWorldJournal. 2010 Nov 4;10:2198-206. doi: 10.1100/tsw.2010.211. ScientificWorldJournal. 2010. PMID: 21057732 Free PMC article. Review.

3

Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.

Braat S, Kooy RF. Braat S, et al. Neuropharmacology. 2015 Jan;88:48-54. doi: 10.1016/j.neuropharm.2014.06.028. Epub 2014 Jul 10. Neuropharmacology. 2015. PMID: 25016041 Review.

4

Fragile X syndrome neurobiology translates into rational therapy.

Braat S, Kooy RF. Braat S, et al. Drug Discov Today. 2014 Apr;19(4):510-9. doi: 10.1016/j.drudis.2014.01.013. Epub 2014 Feb 7. Drug Discov Today. 2014. PMID: 24508819 Review.

5

The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome.

Braat S, D'Hulst C, Heulens I, De Rubeis S, Mientjes E, Nelson DL, Willemsen R, Bagni C, Van Dam D, De Deyn PP, Kooy RF. Braat S, et al. Cell Cycle. 2015;14(18):2985-95. doi: 10.4161/15384101.2014.989114. Cell Cycle. 2015. PMID: 25790165 Free PMC article.

6

The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.

Braat S, Kooy RF. Braat S, et al. Neuron. 2015 Jun 3;86(5):1119-30. doi: 10.1016/j.neuron.2015.03.042. Neuron. 2015. PMID: 26050032 Free article. Review.

7

Metabonomics adds a new dimension to fragile X syndrome.

Heulens I, Braat S, Kooy RF. Heulens I, et al. Among authors: braat s. Genome Med. 2011 Dec 28;3(12):80. doi: 10.1186/gm296. Genome Med. 2011. PMID: 22204589 Free PMC article.

8

Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD.

Logan B, Pascoe EM, Viecelli AK, Johnson DW, Comans T, Hawley CM, Hickey LE, Janda M, Jaure A, Kalaw E, Kiriwandeniya C, Matsuyama M, Mihala G, Nguyen KH, Pole JD, Polkinghorne KR, Pond D, Raj R, Reidlinger DM, Scholes-Robertson N, Valks A, Wong G, Hubbard RE; GOAL Trial Investigators. Logan B, et al. Kidney Int Rep. 2024 Oct 15;10(1):120-133. doi: 10.1016/j.ekir.2024.10.009. eCollection 2025 Jan. Kidney Int Rep. 2024. PMID: 39810773 Free PMC article.

9

Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial.

Pasricha SR, Moya E, Ataíde R, Mzembe G, Harding R, Mwangi MN, Zinenani T, Prang KH, Kaunda J, Mtambo OPL, Vokhiwa M, Mhango G, Mamani-Mategula E, Fielding K, Demir A, Von Dinklage N, Verhoef H, McLean AR, Manda-Taylor L, Braat S, Phiri KS. Pasricha SR, et al. Among authors: braat s. Nat Med. 2025 Jan 13. doi: 10.1038/s41591-025-03492-2. Online ahead of print. Nat Med. 2025. PMID: 39806073 No abstract available.

10

Polysomnographic titration of non-invasive ventilation in motor neurone disease (3TLA): study protocol for a randomised controlled trial.

Berlowitz DJ, Rowe D, Howard ME, Piper A, Graco M, Braat S, Singh B, Souza TV, Lannin N, McLean A, Sawyer A, Carey KA, Ahamed Y; 3TLA Trial Group. Berlowitz DJ, et al. Among authors: braat s. Trials. 2025 Jan 6;26(1):10. doi: 10.1186/s13063-024-08464-4. Trials. 2025. PMID: 39762986 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters